×
Back to Agenda
The Evolving Role of Artificial Intelligence in the Medicinal Product Lifecycle
Session Chair(s)
Hilmar Hamann, PHD
Chief Information Officer, European Medicines Agency, Netherlands
This session will provide perspectives from stakeholders on successes and limitations from practical examples and discuss principles and best practices for maximizing the potential while managing the risks moving forward.
Learning Objective : Describe the current state of the use of artificial intelligence (AI) in the medicinal product lifecycle including its opportunities and challenges; Discuss principles and best practices to maximize potential of AI while managing risks.
Speaker(s)
EMA Update
Platform Architect, European Medicines Agency, Netherlands
Industry Update
Vice President, Head of Technology Innovation, Amgen, Amgen, United States
Industry Update
Principal, Chief Technology Office, Booz Allen Hamilton, United States
Industry Update
Global Head, Quality Excellence Digital | Bioethics Ambassador, F. Hoffmann-La Roche Ltd, Switzerland
Have an account?